What Happened?
Shares of medical lens company STAAR Surgical (NASDAQ: STAA) jumped 3.7% in the afternoon session after investors reacted to positive news in the broader ophthalmology sector as Cencora agreed to acquire EyeSouth Partners' retina business for $1.1 billion.
The deal represented a strategic move for drug distributor Cencora to expand its specialty medical arm and deepen its presence in the fast-growing eye care market. This acquisition brought EyeSouth's retina physicians into Cencora's management services organization, Retina Consultants of America. While the news did not directly involve STAAR Surgical, a major investment of this scale often boosted investor confidence across an entire industry. The deal highlighted a strong outlook for the ophthalmology market as a whole.
The shares closed the day at $18.97, up 2.5% from previous close.
Is now the time to buy STAAR Surgical? Access our full analysis report here, it’s free.
What Is The Market Telling Us
STAAR Surgical’s shares are extremely volatile and have had 31 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.
The biggest move we wrote about over the last year was 8 months ago when the stock gained 45.6% on the news that eye-care company Alcon agreed to acquire the company in an all-cash deal valued at approximately $1.5 billion.
Under the terms of the deal, Alcon paid $28 in cash for each share of STAAR Surgical. This price marked a 51% premium to the company's closing stock price on the previous day. STAAR Surgical manufactured implantable lenses for vision correction, including its EVO family of Implantable Collamer® Lenses. The acquisition allowed Alcon to absorb a key player in the ophthalmic surgery space.
STAAR Surgical is down 19.6% since the beginning of the year, and at $18.97 per share, it is trading 33.6% below its 52-week high of $28.57 from August 2025. Investors who bought $1,000 worth of STAAR Surgical’s shares 5 years ago would now be looking at only $199.98.
WHILE YOU’RE HERE: The Next Palantir? One satellite company captures images of every point on Earth. Every single day. The Pentagon wants it. Hedge funds are using it to beat earnings. You’ve probably never heard of it.
This is what the early days of Palantir looked like before it became a $437 billion giant. Same playbook. Different technology. If you missed Palantir, you need to see this. Claim The Stock Ticker for Free HERE.
